Avadel Pharmaceuticals (AVDL) Revenue (2015 - 2025)
Avadel Pharmaceuticals (AVDL) revenue from Mar 31, 2015 to Sep 30, 2025. The TTM Avadel Pharmaceuticals (AVDL) revenue is $249M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Avadel Pharmaceuticals (AVDL) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +79.88% |
| 5 Years TTM | +49.45% |
| 10 Years TTM | +6.81% |
| All Time TTM | +3.67% |
Annual Revenue change of Avadel Pharmaceuticals (AVDL)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $198M | +17.14% |
| 2024 | $169M | +504.86% |
| 2023 | $28M | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | -100.00% |
| 2020 | $22M | -62.29% |
| 2019 | $59M | -42.66% |
| 2018 | $103M | -40.39% |
| 2017 | $173M | +15.31% |
| 2016 | $150M | -13.16% |
| 2015 | $173M | +1070.57% |
| 2014 | $15M | -34.14% |
| 2013 | $22M | +198.01% |
| 2012 | $7.53M | -76.90% |
| 2011 | $33M | -12.11% |
| 2010 | $37M | -11.94% |
| 2009 | $42M | N/A |
Comparison Avadel Pharmaceuticals (AVDL) five years revenue CAGR with competitors
Avadel Pharmaceuticals (AVDL) five years revenue CAGR is 49.45%.